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The Impact of the Global Financial Crisis on Public Health Expenditures in 
the Economies of the Former Soviet Union 
By Roman Mogilevsky
 
The financial crisis strongly affected the countries of the 
former  Soviet  Union
1  (FSU)  in  2008-2009.  All  of  the 
countries experienced either a recession or a considerable 
slowdown  in  growth.  The  crisis  also  adversely  affected 
government  budget  revenues,  so  governments  had  to 
adjust their expenditures to the falling revenues. Under 
such conditions, public expenditures on health were at risk 
of  being  cut.  This  brief  explores  whether  or  not  this 
actually happened and why or why not. 
 All  of  the  FSU  countries  inherited  health  systems  that 
were  fully  government-owned  and  mostly  government-
funded. During the transition period, Belarus and Ukraine 
introduced  minimal  changes  into  their  health  systems, 
which  were  inherited  from  Soviet  times,  retaining  state 
guarantees  of  universal  and  unlimited  access  to  free 
healthcare. Kyrgyzstan, Moldova and Russia implemented 
major  reforms  of  their  health  systems  which  are  still 
incomplete.  All  three  countries  introduced  mandatory 
health insurance, which includes a minimum guaranteed 
package of health services available to all of the insured 
population  free  of  charge  or  with  a  minor  co-payment. 
Georgia implemented the most radical reform, providing 
publicly  funded  health  services  only  for  the  population 
                                                             
1   Six countries are considered in this analysis: Belarus, Georgia, Kyrgyz 
Republic, Republic of Moldova, Russian Federation, and Ukraine. 
living below the poverty line. In the course of the post-
Soviet  transition,  all  of  these  republics  had  to  reduce 
hospital  facilities.  In  the  three  smaller  countries  of 
Georgia,  Kyrgyzstan,  and  Moldova,  these  adjustments 
were dramatic – two or three-fold reductions, while in 
the  three  larger  countries  of  Belarus,  Russia,  and 
Ukraine, the number of hospitals and beds fell by 20-
40%. The number of primary health units increased in 
Belarus,  Moldova  and  Ukraine,  and  fell  in  the  three 
other countries. The number of health staff—physicians 
and  nurses—mostly  fell;  however,  in  Belarus,  the 
availability of both doctors and nurses increased for the 
same period of time. So, after twenty years of transition, 
the countries’ health systems have diverged significantly 
due to differences in the size of their economies, the 
level of development, the reform path and the policies 
implemented. 
Public expenditures on health in the FSU countries 
Public health expenditures before the crisis 
The share of total health expenditures in GDP in the FSU 
varied from 4.8% GDP in Russia to 10.7% GDP in  
Figure 1. Total health expanditures, 2008 
Sources: World Development Indicators, World Health Organization(WHO) )) 
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Moldova in 2008 (Figure 1a). For comparison, in the EU, 
the median share of total health expenditures in terms of 
GDP was 8.7% in 2008; the median share for the EU new 
member states (NMS) was 7.0% of GDP. 
 As  for  the  absolute  size  of  expenditures,  in  2008,  Russia 
spent 985 current international USD per capita – the highest 
value  among  the  analyzed  countries  (Figure  1b).  Other 
countries  spent  considerably  less.  All  of  these  countries, 
including Russia, spend less on health per capita, not only in 
comparison  to  the  EU,  but  also  in  comparison  to  the  EU 
NMS. 
 The countries also differ widely in terms of 
the role and absolute size of public health 
expenditures  (PHE,  Table  1).  By 
international  comparison,  the  more 
developed a country is, the greater the role 
of  the  public  sector  in  financing  health 
services. However, this is not quite true for 
the six analyzed FSU countries. In terms of 
the  share  of  public  expenditure  in  total 
health  expenditure,  Russia—the  country 
with  the  highest  GDP  per  capita—ranks 
lower  than  Belarus.  On  the  other  end, 
Georgia,  whose  GDP  per  capita  is  1.5-2 
times higher than Kyrgyzstan or Moldova’s, 
has  a  much  lower  share  of  public 
expenditure  in  total  health  expenditures 
than those two countries. These deviations 
from  the  global  trend  originate  in  the 
various directions of healthcare reforms (or 
lack  thereof)  implemented  in  the  post-
Soviet period. 
Among  the  countries  under  consideration, 
Moldova spends the highest share of public 
resources on health (13.0% in 2008); this is 
more  than  the  2008  median  value  of  this 
indicator for the EU NMS (11.9%) and close 
to the EU median (13.6%). Georgia, with its 
relatively  small  government  funding  on 
healthcare, was at the bottom of the list, with PHE equal to 
7.3% of total GG expenditure in 2008. 
Regardless  of  their  differences  in  absolute  and  relative 
levels  of  PHE,  all  of  the  countries  demonstrated  rapid 
growth  in  public  health  expenditures  in  real  terms  in 
2006-2008.  It  seems  that  the  governments  tried  to 
compensate for the chronic under-financing of the health 
sector in previous “poor” years; the lower the level of PHE 
in  previous  years,  the  higher  was  the  compensatory 
effort. 
Public health expenditures during the crisis 
The fiscal situation in 2009 in all of these countries was 
much tighter than in the previous years. This, of course, 
had implications for public health expenditures. 
In 2009, the real growth rate of PHE per capita (Table 1) 
fell  in  comparison  to  2008  in  Georgia,  Moldova  and 
Ukraine,  and  increased  in  Kyrgyzstan,  Belarus  and 
Russia. In Ukraine, the 2009 PHE per capita decline  
 
Table 1. Public expenditures on health before and during 
the crisis 
Sources: WHO, International Monetary Fund, author’s calculations 
took  place  while  the  share  of  PHE  in  total  GG 
expenditure  remained  at  the  2008  level.  This  means 
that  health  expenditures  remained  a  high  priority  but 
fiscal  constraints  led  to  a  reduction  of  health 
expenditures  in  real  terms.  Similarly,  the  PHE  share 
increased in Georgia and Moldova against a slowdown in 
total GG expenditures growth. In Russia, the PHE share 
in  total  GG  expenditures  fell  in  2009  in  spite  of  the 
recorded  increase  in  real  per  capita  PHE  growth  rate. 
Due to these policies, the share of PHE in GDP in 2009 
increased in comparison to 2008 in all countries except 
Ukraine,  where  it  stayed  at  the  2008  level. 
Correspondingly,  PHE  per  capita  in  USD  PPP  terms 
  2006  2007  2008  2009 
Belarus 
PHE, % of total health expenditure  74.7  74.8  72.2  70.6 
PHE, % of total general government (GG) expenditure  9.9  9.5  8.2  8.8 
PHE, % GDP  4.6  4.6  4.0  4.1 
PHE per capita, PPP, current international USD   450  506  497  515 
Real growth rate of PHE per capita, %  -1.2  10.4  -3.2  2.9 
Georgia 
PHE, % of total health expenditure  26.8  27.6  30.9  28.7 
PHE, % of total GG expenditure  7.0  6.3  7.3  7.5 
PHE, % GDP  2.3  2.2  2.7  2.9 
PHE per capita, PPP, current international USD   91  106  134  143 
Real growth rate of PHE per capita, %  30.2  13.5  23.6  5.2 
Kyrgyzstan 
PHE, % of total health expenditure  46.2  49.2  48.4  50.9 
PHE, % of total GG expenditure  13.3  12.8  11.5  11.7 
PHE, % GDP  3.0  3.2  2.8  3.5 
PHE per capita, PPP, current international USD   53  64  60  77 
Real growth rate of PHE per capita, %  27.2  17.4  -8.2  28.1 
Moldova 
PHE, % of total health expenditure  48.4  49.1  50.6  53.7 
PHE, % of total GG expenditure  11.7  11.7  13.0  14.1 
PHE, % GDP  4.7  4.9  5.4  6.4 
PHE per capita, PPP, current international USD   121  134  162  183 
Real growth rate of PHE per capita, %  20.0  8.7  19.2  12.1 
Russia 
PHE, % of total health expenditure  63.2  64.2  64.3  64.4 
PHE, % of total GG expenditure  10.8  10.2  9.2  8.5 
PHE, % GDP  3.3  3.5  3.1  3.5 
PHE per capita, PPP, current international USD   504  581  633  669 
Real growth rate of PHE per capita, %  13.0  12.4  -5.5  4.4 
Ukraine 
PHE, % of total health expenditure  56.7  57.6  55.9  54.7 
PHE, % of total GG expenditure  8.9  9.2  8.6  8.6 
PHE, % GDP  3.9  3.9  3.8  3.8 
PHE per capita, PPP, current international USD   243  275  280  244 
Real growth rate of PHE per capita, %  10.1  9.8  -0.1  -14.6  
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increased in all countries but Ukraine. 
Thus, as follows from the above analysis, PHE have been 
mostly protected in the FSU countries in 2009. In Belarus, 
Kyrgyzstan, Moldova, and Russia, PHE have grown in real 
per capita terms; in Ukraine, where total GG expenditures 
fell dramatically, PHE nevertheless recorded an increased 
share  in  GG.  In  Georgia,  the  PHE  fell  in  2009  in  both 
absolute and relative terms, but this was compensated by 
private  expenditures,  which  were  the  main  source  of 
healthcare financing in this country. 
Health  expenditure  efficiency  and  medium-term 
expenditure outlook 
To assess the sufficiency and efficiency of total and public 
health expenditures, it is worth comparing the resources 
spent  with  the  health  outcomes.  Outcomes  include  life 
expectancy at birth as an integral measure of the health 
status  of  the  population  and  various  mortality  and 
morbidity indicators. 
All of the countries under consideration except for Georgia 
went through a substantial decline in life expectancy in the 
mid-1990s.  In  the  2000s,  all  of  the  analyzed  countries 
except  for  Kyrgyzstan  improved  in  terms  of  the  life 
expectancy  indicator;  this  points  to  a  general 
improvement  in  overall  health  status.  Still,  in  2009,  life 
expectancy in four out of six countries had  
not  returned  to  1989  levels;  only  Georgia  and  Moldova 
have better longevity indicators now than they did at the 
end  of  the  Soviet  period.  In  all  of  these  countries,  life 
expectancy is now much lower than in the EU (10 years or 
more) and in the EU NMS. However, life expectancy in the 
analyzed  countries  has  very  little  correlation  with  a 
country’s income status or health expenditures. This lack 
of correlation indicates that there are important factors 
influencing the health status of the population, which are 
not  directly  related  to  the  healthcare  system  such  as 
environment, nutrition, lifestyle etc. Simultaneously, this 
also raises doubts about the efficiency of health spending 
in these countries. 
Large differences between countries also exist in terms of 
the under-five mortality rate (U5MR). The values of this 
indicator  are  much  higher  in  the  FSU  than  in  other 
European countries. It follows from the analysis that there 
is  a  strong  positive  statistical  relationship  between  the 
U5MR and the fertility rate, i.e., the average number of 
children born per woman. After controlling for fertility, the 
U5MR appears to be strongly and negatively dependent on 
public health expenditure per capita, i.e., ceteris paribus, 
the higher the public health expenditures, the lower the 
child mortality. 
Two main messages seem to emerge from this discussion. 
First, health spending is not the only factor determining 
the  health  status  of  a  population;  the  various  socio-
economic factors mentioned above are also important 
health  determinants.  From  this  perspective,  in  many 
cases it could be more efficient to implement policies 
promoting  healthy  lifestyles  than  to  rely  on  narrowly-
understood healthcare interventions.  
Second, the absolute level of health spending is what 
matters for the effectiveness of healthcare. In order to 
improve  a  population’s  health,  the  analyzed  countries 
need to significantly increase health spending. In many 
of  these  countries  (especially  in  Russia),  this  would 
require  increasing  the  share  of  total  government 
resources allocated for healthcare. Most probably, this 
should also be accompanied by an increasing reliance on 
private sources of health financing, especially in those 
countries which currently rely heavily on public sources 
and where there is no fiscal space for further expansion 
of public health spending (Belarus, Moldova, Ukraine). 
In  the  medium-  to  long-term,  all  analyzed  countries 
except for Kyrgyzstan will have to increase their health 
spending  due  to  rapid  population  ageing.  Smaller 
countries will also have to think about the necessity of 
replacing external financing sources with domestic ones. 
The required increase in health spending may create a 
heavy  fiscal  burden  for  these  countries.  In  such  a 
situation,  a  radical  improvement  in  the  efficiency  of 
health  spending  should  be  a  key  priority.  Targeting 
efficiency  would  require  implementing  politically 
difficult  health  reforms  in  those  countries  that  have 
hesitated to initiate them so far (Belarus and Ukraine), 
and  continuing  them  in  other  countries.  This  includes 
adjustments in the sector’s physical infrastructure and 
staff, the introduction of minimally guaranteed packages 
of  services,  well-thought  out  reforms  in  financing 
mechanisms  with  a  simultaneous  strengthening  of 
primary healthcare, increases in investments in modern 
health  equipment,  the  retraining  of  health  personnel, 
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